Discuss This Drug

erythromycin A

CHEBI:CHEBI_42355

Definition

An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively.

Chemical Information

Molecular Formula
C37H67NO13
Molecular Mass
733.92680
Charge
0
SMILES
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
InChI
InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
InChIKey
ULGZDMOVFRHVEP-RWJQBGPGSA-N

Alternative Names

  • 3''-O-demethylerythromycin
  • Abomacetin
  • eritromicina
  • erthromycin
  • erythromycin
  • erythromycin
  • Erythromycin
  • ERYTHROMYCIN
  • Erythromycin A
  • ERYTHROMYCIN A
  • Erythromycin C
  • erythromycine
  • erythromycinum
  • (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
  • (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

oboInOwl#hasDbXref
Reaxys:75279
core#notation
CHEBI:42355

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

dosage_form
GRANULE, FOR SUSPENSION
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
labeler_name
SM BIOMED SDN.BHD.
application_number
NDA050617
product_ndc
52536-105
brand_name_base
Erythromycin ethylsuccinate
route
OPHTHALMIC
package_ndc
52334-001-01
spl_id
0d6bef61-c1ba-1b9c-e063-6294a90a8bda
oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#hasDbXref
Reaxys:75279
oboInOwl#hasAlternativeId
CHEBI:4843
oboInOwl#id
CHEBI:42355
generic_name
Erythromycin Estolate
brand_name
Ery
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_48844
chebi#is_conjugate_base_of
http://purl.obolibrary.org/obo/CHEBI_64268
package_description
25 kg in 1 CARTON (52334-001-01)
listing_expiration_date
20241231
marketing_start_date
20130910
rxcui
1668264
unii
33H58I7GLQ
spl_set_id
bccdb8f3-b5f5-4f07-8ddb-8811d5c1b73c
manufacturer_name
ARMAS PHARMACEUTICALS INC.
package_marketing_start_date
20200707
active_ingredient_name
ERYTHROMYCIN ESTOLATE
active_ingredient_strength
1200 mg/30g
nui
N0000175877
upc
0375834294018
core#notation
CHEBI:42355
pharm_class_epc
Macrolide [EPC]
pharm_class
Macrolide [EPC]
pharm_class_cs
Macrolides [CS]
pharm_class_pe
Decreased Sebaceous Gland Activity [PE]
brand_name_suffix
400
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect23858
chebi#is_conjugate_acid_of
http://purl.obolibrary.org/obo/CHEBI_64268
owl#annotatedSource
t218036
owl#someValuesFrom
t265103